Journal article

Emerging Mitochondrial Therapeutic Targets in Optic Neuropathies

MIG Lopez Sanchez, JG Crowston, DA Mackey, IA Trounce

Pharmacology and Therapeutics | PERGAMON-ELSEVIER SCIENCE LTD | Published : 2016

Abstract

Optic neuropathies are an important cause of blindness worldwide. The study of the most common inherited mitochondrial optic neuropathies, Leber hereditary optic neuropathy (LHON) and autosomal dominant optic atrophy (ADOA) has highlighted a fundamental role for mitochondrial function in the survival of the affected neuron—the retinal ganglion cell. A picture is now emerging that links mitochondrial dysfunction to optic nerve disease and other neurodegenerative processes. Insights gained from the peculiar susceptibility of retinal ganglion cells to mitochondrial dysfunction are likely to inform therapeutic development for glaucoma and other common neurodegenerative diseases of aging. Despite..

View full abstract